A NEW CLINICAL RESEARCH has shown that after 90 days of supplementation, Mnemosyss® resulted in a significant improvement in episodic memory performance compared to placebo, assessed using standardized neuropsychological tests, particularly during complex tasks. Its effectiveness on cognitive function has been demonstrated in a randomized, double-blind, placebo-controlled clinical study conducted in adults aged 60 to 73 with mild, non-pathological cognitive decline. Additional benefits were observed in working memory and cognitive strategies, reflecting improved efficiency in information processing and retrieval.
Mnemosyss® is a patented natural marine ingredient, derived from sardine by-products through an eco-friendly enzymatic hydrolysis process. From a nutritional standpoint, it is characterized by a unique and synergistic composition combining low molecular weight marine peptides, offering high bioavailability and digestibility, marine omega-3 fatty acids, including EPA and DHA, and a natural source of vitamin B12, which contributes to normal brain function.
The health benefits of Mnemosyss® are backed by more than nine years of research, including the BrainBooster collaborative R&D project (funded by the Brittany Region and BPI France), and rely on a solid scientific foundation comprising preclinical, mechanistic, and published clinical studies. As part of this scientific program, the team sought to understand how marine bioactives could influence the complex biological processes that gradually impair cognitive function with age. This approach considered the fact that cognitive decline is not due to a single mechanism but rather to the progressive interaction of several hallmarks of brain ageing such as neuroinflammation, oxidative stress, gut microbiota dysbiosis and chronic stress. A series of preclinical studies has indeed demonstrated that Mnemosyss® promotes healthy brain ageing and helps limit age-related cognitive decline by targeting several biological pathways involved in memory, inflammation, stress, and the gut–brain axis.
Thanks to its multi-target mode of action, robust scientific data, and preventive approach, Mnemosyss® represents a relevant nutritional solution for supporting cognitive ageing and addressing the growing challenges related to brain health within a well-ageing approach.
To learn more about the clinical study: https://doi.org/10.1016/j.ajcnut.2026.101360
EPA, bioactives, Mnemosyss, DHA, ageing, healthy, chronicstress, research, omega-3, clinical research, cognitive function,
